|
 |
 |
|
Details For Selected Brain Tumor Treatment
|
 |
|
|
| Sponsored By |
|
| Please Click On The Above Banner For More Details |
|
|
 |
 |
 |
 |
 |
 |
Treatment Name: |
 |
AutoLITT™ FIM Trial - A Prospective First-In-Man (FIM) Safety Trial of the AutoLITT Laser Treatment of Recurrent/Progressive Brain Tumors |
 |
 |
 |
 |
Phase: |
 |
Phase 1 |
 |
 |
 |
 |
 |
 |
Treatment ID#: |
 |
1879 |
 |
 |
 |
 |
Age Group: |
 |
Adults Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
Not Specified |
 |
 |
 |
 |
Conditions: |
 |
Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
09/28/2008 |
 |
 |
 |
 |
Tumor Types: |
 |
Glioblastoma Multiforme |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
|
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Surgery |
 |
 |
 |
 |
Contact: |
 |
Gene Barnett M.D. Professor and Chairman Brain Tumor Institute Cleveland Clinic Brain Tumor and Neuro-Oncology Center R20 9500 Euclid Ave. Cleveland, OH 44195 USA Phone: 216-445-1379 Fax: 216-444-0924 E-mail: barnett@neus.ccf.org Website: ccf.org |
 |
 |
- Last updated refers to the date when our listing for each treatment was last updated.
- ID is a combination of our internal ID and the official ID for the trial, if any.
- Min Karnofsky is a general guide to how well you have to function to use this treatment
|
|
|